Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT04334993
Status:
UNKNOWN
Last Update Posted:
2021-05-07
First Post:
2020-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Sponsor:
Israeli Medical Association
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AYA001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None